MedTrace Logo

The AIM Study: Assessing the Impact of Margin Reduction

NCT00754000 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 82

Last updated 2012-04-30

No results posted yet for this study

Summary

This study will observe patients who receive external beam radiation for prostate cancer. These patients will be localized and tracked (targeted) with the Calypso 4D Localization System. These patients will have a uniform treatment plan with reduced PTVs (prostate treatment volume) and will be assessed at multiple time points for quality of life and side effects related to radiation therapy.

Conditions

Interventions

OTHER

Observation

AE monitoring and EPIC QOL survey

Sponsors & Collaborators

  • Varian, a Siemens Healthineers Company

    lead INDUSTRY

Principal Investigators

  • Constantine Mantz, MD · GenesisCare USA

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-07-31
Completion
2009-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00754000 on ClinicalTrials.gov